I agree it isn't so much of what specific abuse resistant opioid is released but that Elite gets a couple of them to market. Saying that I do think given Elite's pipeline the likely candidate is Hydromorphone first.
However, to say that the PPS predictions did not come true misses the point that the company almost went bankrupt and the PPS went as low as the .03's and we are sitting between .10~.12 currently. In addition, I see few people continuing to predict $1 or $5. I see people talking about their excitement that Elite will be producing a whole line of abuse resistant opioids. And, yes, I do believe Jerry Treppel when he says that is what the company is heading towards including the Nasdaq.
Market Data 
Markets 
AI
